Disclosures for "Semaphorin 4A (Sema4A) as a Biomarker for Demyelination in Multiple Sclerosis"
-
Dr. Appleberry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Appleberry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Appleberry has received research support from Genentech.
-
The institution of Dr. Lee has received research support from NIH.
-
Dr. Zhu has nothing to disclose.
-
Ms. Zeng has nothing to disclose.
-
Dr. Karikari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Quanterix Corporation. Dr. Karikari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spearbio. Dr. Karikari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Dr. Karikari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogen Biomarking .
-
The institution of Dr. Xia has received research support from National Institute of Health. The institution of Dr. Xia has received research support from Genentech/Roche.